Td Asset Management Inc Insmed Inc Transaction History

Td Asset Management Inc

  • $106 Billion
  • Q4 2024

A detailed history of Td Asset Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Td Asset Management Inc holds 526,890 shares of INSM stock, worth $39.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
526,890
Previous 513,082 2.69%
Holding current value
$39.5 Million
Previous $37.5 Million 2.88%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$66.29 - $76.63 $915,332 - $1.06 Million
13,808 Added 2.69%
526,890 $36.4 Million
Q3 2024

Nov 01, 2024
SELL
$62.0 - $79.01 $781,200 - $995,526
-12,600 Reduced 2.4%
513,082 $37.5 Million
Q2 2024

Aug 02, 2024
BUY
$22.0 - $69.71 $2.17 Million - $6.87 Million
98,504 Added 23.06%
525,682 $35.2 Million
Q1 2024

May 08, 2024
SELL
$25.72 - $29.94 $935,024 - $1.09 Million
-36,354 Reduced 7.84%
427,178 $11.6 Million
Q4 2023

Feb 12, 2024
SELL
$23.42 - $31.74 $1.4 Million - $1.89 Million
-59,600 Reduced 11.39%
463,532 $14.4 Million
Q3 2023

Oct 27, 2023
BUY
$19.86 - $26.93 $3.86 Million - $5.23 Million
194,145 Added 59.01%
523,132 $13.2 Million
Q2 2023

Aug 09, 2023
SELL
$16.44 - $21.1 $261,889 - $336,123
-15,930 Reduced 4.62%
328,987 $6.94 Million
Q1 2023

May 10, 2023
SELL
$16.26 - $21.73 $53,056 - $70,904
-3,263 Reduced 0.94%
344,917 $5.88 Million
Q4 2022

Feb 06, 2023
BUY
$16.98 - $23.15 $47,730 - $65,074
2,811 Added 0.81%
348,180 $6.96 Million
Q3 2022

Nov 07, 2022
SELL
$20.88 - $28.21 $138,643 - $187,314
-6,640 Reduced 1.89%
345,369 $7.55 Million
Q2 2022

Aug 04, 2022
SELL
$17.07 - $25.71 $84,957 - $127,958
-4,977 Reduced 1.39%
352,009 $6.94 Million
Q1 2022

May 10, 2022
SELL
$20.42 - $28.13 $652,949 - $899,484
-31,976 Reduced 8.22%
356,986 $8.39 Million
Q4 2021

Feb 10, 2022
BUY
$25.89 - $33.45 $2.96 Million - $3.82 Million
114,230 Added 41.58%
388,962 $10.6 Million
Q3 2021

Nov 09, 2021
SELL
$22.46 - $29.47 $123,440 - $161,967
-5,496 Reduced 1.96%
274,732 $7.57 Million
Q2 2021

Aug 11, 2021
BUY
$24.17 - $36.01 $709,727 - $1.06 Million
29,364 Added 11.71%
280,228 $6.89 Million
Q1 2021

May 14, 2021
BUY
$32.28 - $44.3 $1.7 Million - $2.33 Million
52,626 Added 26.55%
250,864 $8.54 Million
Q4 2020

Feb 16, 2021
BUY
$31.45 - $40.54 $541,443 - $697,936
17,216 Added 9.51%
198,238 $6.6 Million
Q3 2020

Nov 10, 2020
SELL
$26.0 - $34.5 $78,000 - $103,500
-3,000 Reduced 1.63%
181,022 $5.82 Million
Q2 2020

Aug 13, 2020
BUY
$14.11 - $29.42 $988,080 - $2.06 Million
70,027 Added 61.43%
184,022 $5.07 Million
Q1 2020

May 15, 2020
BUY
$13.63 - $33.98 $44,979 - $112,133
3,300 Added 2.98%
113,995 $1.83 Million
Q4 2019

Feb 11, 2020
SELL
$16.12 - $24.98 $175,708 - $272,282
-10,900 Reduced 8.96%
110,695 $2.64 Million
Q3 2019

Nov 07, 2019
SELL
$15.49 - $25.78 $89,082 - $148,260
-5,751 Reduced 4.52%
121,595 $2.15 Million
Q2 2019

Aug 01, 2019
SELL
$23.0 - $32.19 $749,800 - $1.05 Million
-32,600 Reduced 20.38%
127,346 $3.26 Million
Q1 2019

May 08, 2019
SELL
$13.91 - $31.15 $304,629 - $682,185
-21,900 Reduced 12.04%
159,946 $4.65 Million
Q4 2018

Feb 01, 2019
SELL
$11.6 - $18.7 $646,120 - $1.04 Million
-55,700 Reduced 23.45%
181,846 $2.39 Million
Q3 2018

Nov 01, 2018
SELL
$18.95 - $28.08 $533,423 - $790,423
-28,149 Reduced 10.59%
237,546 $4.8 Million
Q2 2018

Jul 31, 2018
BUY
$20.0 - $29.72 $116,000 - $172,376
5,800 Added 2.23%
265,695 $6.28 Million
Q1 2018

May 11, 2018
SELL
$21.69 - $32.99 $19,521 - $29,691
-900 Reduced 0.35%
259,895 $5.85 Million
Q4 2017

Feb 02, 2018
SELL
$26.43 - $31.78 $2,643 - $3,178
-100 Reduced 0.04%
260,795 $8.13 Million
Q3 2017

Nov 09, 2017
BUY
$11.61 - $31.21 $3.03 Million - $8.14 Million
260,895
260,895 $8.14 Million

Others Institutions Holding INSM

# of Institutions
498
Shares Held
189M
Call Options Held
3.21M
Put Options Held
2.72M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email